Glucagon‐like peptide‐1 receptor agonist, liraglutide, reduces heroin self‐administration and drug‐induced reinstatement of heroin‐seeking behaviour in rats-Reference-Cited by-同舟云学术

Glucagon‐like peptide‐1 receptor agonist, liraglutide, reduces heroin self‐administration and drug‐induced reinstatement of heroin‐seeking behaviour in rats

Published:2021-11-21 Issue:2 Volume:27 Page:
ISSN:1355-6215
Container-title:Addiction Biology
language:en
Short-container-title:Addiction Biology

Author:

Douton Joaquin E.¹,Horvath Nelli²,Mills‐Huffnagle Sara²,Nyland Jennifer E.²^ORCID,Hajnal Andras²,Grigson Patricia S.²^ORCID

Affiliation:

1. Department of Psychology and Neuroscience University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

2. Department of Neural and Behavioral Sciences Penn State College of Medicine Hershey Pennsylvania USA

Funder

Pennsylvania Department of Health

National Institute on Drug Abuse

Publisher

Wiley

Subject

Psychiatry and Mental health,Pharmacology,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/adb.13117

Reference47 articles.

2. Drugs of Abuse and the Brain

3. Release from Prison — A High Risk of Death for Former Inmates

4. Centers for Disease control and Prevention.Accessed March 29 2018.https://www.cdc.gov/drugoverdose/epidemic/index.html

5. AlterS YeagerC.The Consequences of Covid‐19 on the Overdose epidemic: Overdoses are Increasing. Overdose Detection Mappling Application Program.2020.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target;Pharmacological Research;2024-09

2. Liraglutide alleviated alpha-pyrrolidinovalerophenone (α-PVP) induced cognitive deficits in rats by modifying brain mitochondrial impairment;European Journal of Pharmacology;2024-09

3. Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorder;Addiction Science & Clinical Practice;2024-07-27

4. The emerging role of glucagon-like peptide 1 in binge eating;Journal of Endocrinology;2024-04-17

5. Short-term effects of semaglutide among patients with obesity with and without food addiction: an observational study;Journal of Addictive Diseases;2024-02-18